Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/Expansion Study of Dasatinib
- Status
- TERMINATED
- Phase
- PHASE1
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2